Literature DB >> 14690486

Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment.

A A Shokeir1.   

Abstract

Squamous cell carcinoma (SCC) can occur in both nonbilharzial and bilharzial bladders; the two subtypes differ in epidemiology, pathogenesis and clinicopathological features. The nonbilharzial type occurs in Western countries and represents < 5% of all vesical tumours; it occurs most often in the seventh decade with a slight male predominance. The principal predisposing factor is prolonged indwelling urethral catheterization in patients with spinal cord injury and the main symptom is haematuria. Patients are usually diagnosed at an advanced stage and most of the tumours are of moderate and high grades. At cystoscopy tumours are predominantly ulcerative and commonly involve the trigone and lateral walls. Although distant metastasis is infrequent (8-10%) the prognosis is grave and most patients die after failure of locoregional control; radical cystectomy provides the best therapy. To avoid nonbilharzial SCC, patients with spinal cord injury should be free of catheterization if possible. The outcome can be improved by early detection with frequent cytology, cystoscopy and biopsy. Bilharzial SCC occurs commonly in the Middle East, South-east Asia and South America where schistosomiasis is endemic. In an Egyptian series SCC represented 59% of 1026 cystectomy specimens. The tumour is diagnosed in the fifth decade, and five times more common in men than women. Bladder carcinogenesis is probably related to bacterial and viral infections, commonly associated with bilharzial infestation rather than the parasite itself. The presentation is often with irritative bladder symptoms and haematuria, and many patients present at an advanced stage, although most tumours are of low and moderate grades. At cystoscopy tumours are predominantly nodular and usually arise from the upper vesical hemisphere. Lymph-node metastasis occurs in approximately 19% and significantly decreases survival; radical cystectomy remains the main treatment, giving a 5-year survival rate of 50%. Early detection improves the therapeutic yield and prevention is possible by combining snail control and mass therapy of the infested rural population by oral antibilharzial drugs.

Entities:  

Mesh:

Year:  2004        PMID: 14690486     DOI: 10.1111/j.1464-410x.2004.04588.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  38 in total

Review 1.  Neoadjuvant chemotherapy for bladder cancer.

Authors:  Peter C Black; Gordon A Brown; H Barton Grossman; Colin P Dinney
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 2.  Variant forms of bladder cancer: basic considerations on treatment approaches.

Authors:  Francesc Pons; Anna Orsola; Juan Morote; Joaquim Bellmunt
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

Review 3.  Urothelial carcinoma of the bladder: definition, treatment and future efforts.

Authors:  Sandip M Prasad; G Joel Decastro; Gary D Steinberg
Journal:  Nat Rev Urol       Date:  2011-10-11       Impact factor: 14.432

Review 4.  A practical approach to difficult urinary catheterizations.

Authors:  Cameron Ghaffary; Amanuel Yohannes; Carlos Villanueva; Stephen W Leslie
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 5.  Urothelial generation and regeneration in development, injury, and cancer.

Authors:  Caihong Wang; Whitney Trotter Ross; Indira U Mysorekar
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

6.  Risk factors for development of primary bladder squamous cell carcinoma.

Authors:  K V Manley; R Hubbard; D Swallow; W Finch; S J Wood; S M Biers
Journal:  Ann R Coll Surg Engl       Date:  2016-11-21       Impact factor: 1.891

7.  Do pure squamous cell carcinomas and urothelial carcinomas have similar prognosis after radical cystectomy?

Authors:  Ugur Balci; Kutan Ozer; Sacit Nuri Gorgel; Ertugrul Sefik; Cengiz Girgin; Cetin Dincel
Journal:  World J Urol       Date:  2012-04-28       Impact factor: 4.226

8.  Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract.

Authors:  Jung Yong Hong; Moon Ki Choi; Ji Eun Uhm; Min Jae Park; Jeeyun Lee; Se Hoon Park; Joon Oh Park; Won Seog Kim; Won Ki Kang; Hyun Moo Lee; Han Yong Choi; Hoyeong Lim
Journal:  Med Oncol       Date:  2008-11-06       Impact factor: 3.064

9.  Incidence analyses of bladder cancer in the Nile delta region of Egypt.

Authors:  Stacey A Fedewa; Amr S Soliman; Kadry Ismail; Ahmed Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Hoda G Omar; Jerome Nriagu; Mark L Wilson
Journal:  Cancer Epidemiol       Date:  2009-09-16       Impact factor: 2.984

10.  Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration.

Authors:  Douglas W Strand; David J DeGraff; Ming Jiang; Mansoureh Sameni; Omar E Franco; Harold D Love; William J Hayward; Opal Lin-Tsai; Anne Y Wang; Justin M M Cates; Bonnie F Sloane; Robert J Matusik; Simon W Hayward
Journal:  Am J Pathol       Date:  2012-12-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.